Health Condition 1: B359- Dermatophytosis, unspecified
Conditions
Interventions
Intervention1: Qurs Asfar and Zimad e Bars: 1Tablet (775mg) twice daily to be taken orally with water and powder as required locally on affected part after rubbing for few seconds twice daily for 6 we
Sponsors
Central Council for Research in Unani Medicine CCRUM New Delhi
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients of either sex in the age group of 18-65 years. 2. Subjects confirmed by direct microscopy 3. Clinical signs and symptoms suggestive of fungal infection
Exclusion criteria
Exclusion criteria: 1. Subjects on topical treatment within 2 weeks prior to entry into the study 2. Subjects on systemic therapy within 4 weeks prior to entry into the study 3. Subjects with Tinea capitis (tinea of scalp), Onychomycosis (tinea of nails) and Tinea barbae (tinea of beard) 4. Known cases of allergy to any ingredients of the study drug. 5. Subjects with history of diabetes mellitus and systemic illness requiring long-term treatment. 6. Lactating and pregnant women
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Improvement in signs and symptoms of Qooba (Dermatophytosis) i.e. Annular/arcuate polycyclic lesion with clear centre, Papulo-vesiculation at margin, Scaling at margin, Erythema, Itching and Burning Timepoint: At baseline, Day 14, 28 and 42. | — |
Secondary
| Measure | Time frame |
|---|---|
| Haematological and biochemical assessment for safety assessment i.e. CBC, LFT, KFT, Urine Routine & microscopic examination.Timepoint: At baseline and end of treatment i.e. day 42 | — |
Countries
India
Contacts
Public ContactDr Pradeep Kumar
Central Council for Research in Unani Medicine (CCRUM)
Outcome results
None listed